A novel NF-κ B/YY1/microRNA-10a regulatory circuit in fibroblast-like synoviocytes regulates inflammation in rheumatoid arthritis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Mu, Nan ^a   Gu, Jintao ^a   Huang, Tonglie ^a   Zhang, Cun ^a   Shu, Zhen ^a   Li, Meng ^a   Hao, Qiang ^a   Li, Weina ^a   Zhang, Wangqian ^a   Zhao, Jinkang ^b   Zhang, Yong ^c   Huang, Luyu ^b   Wang, Shuning ^a   Jin, Xiaohang ^a   Xue, Xiaochang ^a   Zhang, Wei ^a   Zhang, Yingqi ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 1BETA; IRAK4 PROTEIN, HUMAN; LILRB2 PROTEIN, HUMAN; MAP KINASE KINASE KINASE 7; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; TRANSCRIPTION FACTOR YY1; TUMOR NECROSIS FACTOR;

BINDING SITE; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; RHEUMATOID ARTHRITIS; RNA INTERFERENCE; SYNOVIOCYTE; SYNOVIUM;

ARTHRITIS, RHEUMATOID; BASE SEQUENCE; BINDING SITES; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-1BETA; MAP KINASE KINASE KINASES; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MODELS, BIOLOGICAL; NF-KAPPA B; RECEPTORS, IMMUNOLOGIC; RNA INTERFERENCE; SYNOVIAL MEMBRANE; SYNOVIOCYTES; TUMOR NECROSIS FACTOR-ALPHA; YY1 TRANSCRIPTION FACTOR;

EID: 84956633214     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20059     Document Type: Article

References (52)

1. Noss, E. H., Brenner, M. B. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol. Rev. 223, 252-270 (2008).
2. Kim, S. J. et al. Induction of MMP-13 expression by soluble human glucocorticoid-induced tumor necrosis factor receptor in fibroblast-like synovial cells. Osteoarthritis Cartilage. 14, 146-153 (2006).
3. Chang, S. K., Gu, Z., Brenner, M. B. Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. Immunol. Rev. 233, 256-266 (2010).
4. Bartok, B., Firestein, G. S. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol. Rev. 233, 233-255 (2010).
5. Yoshioka, Y. et al. Suppression of hyaluronan synthesis alleviates inflammatory responses in murine arthritis and in human rheumatoid synovial fibroblasts. Arthritis Rheum. 65, 1160-1170 (2013).
6. Huh, J. E. et al. WIN-34B, a new herbal medicine, inhibits the inflammatory response by inactivating IkappaB-alpha phosphorylation and mitogen activated protein kinase pathways in fibroblast-like synoviocytes. J. Ethnopharmacol. 143, 779-786 (2012).
7. Xu, L. et al. IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients. Arthritis Res. Ther. 15, R170 (2013).
8. Tian, J., Chen, J. W., Gao, J. S., Li, L., Xie, X. Resveratrol inhibits TNF-alpha-induced IL-1beta, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway. Rheumatol. Int. 33, 1829-1835 (2013).
9. Chen, K., Rajewsky, N. The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. 8, 93-103 (2007).
10. Du, T., Zamore, P. D. Beginning to understand microRNA function. Cell Res. 17, 661-663 (2007).
11. Shi, Z. et al. miR-9 and miR-140-5p Target FoxP2 and Are Regulated as a Function of the Social Context of Singing Behavior in Zebra Finches. J. Neurosci. 33, 16510-16521 (2013).
12. Cao, J. et al. miR-129-3p controls cilia assembly by regulating CP110 and actin dynamics. Nat. Cell Biol. 14, 697-706 (2012).
13. Nakasa, T. et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 58, 1284-1292 (2008).
14. Chan, E. K., Satoh, M., Pauley, K. M. Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need? Arthritis Rheum. 60, 912-915 (2009).
15. Tan, L. et al. Circulating miR-125b as a biomarker of Alzheimer's disease. J. Neurol. Sci. 336, 52-56 (2013).
16. Wei, F. et al. miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer. Mol. Cancer. 12, 81 (2013).
17. Wu, W. et al. miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD. Gut. 64, 1755-1764 (2015).
18. Guan, H. et al. MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis. Eur. J. Immunol. 43, 104-114 (2013).
19. Ghorpade, D. S., Sinha, A. Y., Holla, S., Singh, V., Balaji, K. N. NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease. J. Biol. Chem. 288, 33037-33048 (2013).
20. Lin, J. et al. A Novel p53/microRNA-22/Cyr61 Axis in Synovial Cells Regulates Inflammation in Rheumatoid Arthritis. Arthritis Rheumatol. 66, 49-59 (2014).
21. Li, X., Tian, F., Wang, F. Rheumatoid arthritis-associated microRNA-155 targets SOCS1 and upregulates TNF-alpha and IL-1beta in PBMCs. Int. J. Mol. Sci. 14, 23910-23921 (2013).
22. Murata, K. et al. miR-451 downregulates neutrophil chemotaxis via p38 MAPK. Arthritis Rheumatol. 66, 549-559 (2014).
23. Philippe, L. et al. MiR-20a regulates ASK1 expression and TLR4-dependent cytokine release in rheumatoid fibroblast-like synoviocytes. Ann. Rheum. Dis. 72, 1071-1079 (2013).
24. Nakamachi, Y. et al. MicroRNA-124 inhibits the progression of adjuvant-induced arthritis in rats. Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2014-206417 (2015).
25. Alsaleh, G. et al. MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts. Plos One. 9, e111266 (2014).
26. Xue, X. et al. Downregulation of MicroRNA-107 in intestinal CD11c, myeloid cells in response to microbiota and proinflammatory cytokines increases IL-23p19 expression. Eur. J. Immunol. 44, 673-682 (2013).
27. Cornall, R. J. et al. Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/Ity/Bcg genes on chromosome 1. Nature. 353, 262-265 (1991).
28. Ma, J. et al. NF-kappaB-dependent microRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1beta induction. Mol. Cancer. 13, 40 (2014).
29. Strober, W., Fuss, I. J. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 140, 1756-1767 (2011).
30. Rossol, M. et al. Tumor necrosis factor receptor type I expression of CD4+ T cells in rheumatoid arthritis enables them to follow tumor necrosis factor gradients into the rheumatoid synovium. Arthritis Rheum. 65, 1468-1476 (2013).
31. Bottini, N., Firestein, G. S. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat. Rev. Rheumatol. 9, 24-33 (2013).
32. Dasuri, K. et al. The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res. Ther. 6, R161-168 (2004).
33. Hah, Y. S. et al. A20 suppresses inflammatory responses and bone destruction in human fibroblast-like synoviocytes and in mice with collagen-induced arthritis. Arthritis Rheum. 62, 2313-2321 (2010).
34. Tak, P. P., Firestein, G. S. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 107, 7-11 (2001).
35. Yeremenko, N. et al. TNF-alpha and IL-6 differentially regulate Dkk-1 in the inflamed arthritic joint. Arthritis Rheumatol. 67, 2071-2075 (2015).
36. Zamora-Atenza, C. et al. Adalimumab regulates intracellular TNFalpha production in patients with rheumatoid arthritis. Arthritis Res. Ther. 16, R153 (2014).
37. Bossaller, L., Rothe, A. Monoclonal antibody treatments for rheumatoid arthritis. Expert Opin. Biol. Ther. 13, 1257-1272 (2013).
38. Fukuda, S. et al. Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis. Bmc Musculoskel Dis. 15, 275 (2014).
39. Fischer, J. A. et al. Combined inhibition of tumor necrosis factor alpha and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody. Arthritis Rheumatol. 67, 51-62 (2015).
40. de la Rica, L. et al. Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expression. J. Autoimmun. 41, 6-16 (2013).
41. Mi, S., Zhang, J., Zhang, W., Huang, R. S. Circulating microRNAs as biomarkers for inflammatory diseases. Microrna. 2, 63-71 (2013).
42. Stanczyk, J. et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 58, 1001-1009 (2008).
43. Nakamachi, Y. et al. MicroRNA-124a Is a Key Regulator of Proliferation and Monocyte Chemoattractant Protein 1 Secretion in Fibroblast-like Synoviocytes From Patients With Rheumatoid Arthritis. Arthritis Rheum. 60, 1294-1304 (2009).
44. Churov, A. V., Oleinik, E. K., Knip, M. MicroRNAs in rheumatoid arthritis: Altered expression and diagnostic potential. Autoimmu. Rev. 14, 1029-1037 (2015).
45. Tang, Y. et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60, 1065-1075 (2009).
46. Xue, X. C. et al. Microbiota Downregulates Dendritic Cell Expression of miR-10a, Which Targets IL-12/IL-23p40. J. Immunol. 187, 5879-5886 (2011).
47. Wu, W. et al. miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD. Gut. 64, 1755-1764 (2015).
48. McInnes, I. B., Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429-442 (2007).
49. Smolen, J. S., Aletaha, D., Koeller, M., Weisman, M. H., Emery, P. New therapies for treatment of rheumatoid arthritis. Lancet. 370, 1861-1874 (2007).
50. Xu, L. L., Warren, M. K., Rose, W. L., Gong, W., Wang, J. M. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J. leukoc. Biol. 60, 365-371 (1996).
51. Min, D. J. et al. Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts. Arthritis Rheum. 50, 1146-1155 (2004).
52. Zhao, W. et al. The discoidin domain receptor 2/annexin A2/matrix metalloproteinase 13 loop promotes joint destruction in arthritis through promoting migration and invasion of fibroblast-like synoviocytes. Arthritis Rheumatol. 66, 2355-2367 (2014).